A blinded, randomized and controlled multicenter clinical trial to assess the efficacy and safety of Leisguard® as an immunotherapeutic treatment for healthy Leishmania infantum-seropositive dogs

  1. Baxarias, M.
  2. Donato, G.
  3. Mateu, C.
  4. Salichs, M.
  5. Homedes, J.
  6. Miró, G.
  7. Pennisi, M.G.
  8. Solano-Gallego, L.
Revista:
Parasites & vectors

ISSN: 1756-3305

Any de publicació: 2023

Volum: 16

Número: 1

Pàgines: 344

Tipus: Article

DOI: 10.1186/S13071-023-05903-0 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus